2018
DOI: 10.1159/000492945
|View full text |Cite
|
Sign up to set email alerts
|

The Precuneus – A Witness for Excessive Aβ Gathering in Alzheimer’s Disease Pathology

Abstract: Evidence of cortical beta-amyloid (Aβ) load, assessed by Aβ positron emission tomography (Aβ-PET), is an established in vivo biomarker of Alzheimer’s disease (AD)-related pathophysiology. Qualitative assessment of Aβ-PET provides binary information; meanwhile semiquantitative approaches require a parcellation of PET image either manually or by placement of atlas-based volumes of interest. We supposed that a whole-brain approach with voxel-by-voxel standardized uptake value ratio (SUVr) parametric images may be… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
10
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(11 citation statements)
references
References 27 publications
0
10
1
Order By: Relevance
“…These QTs have been reported in the past. It was confirmed in [22][23][24]. The JSCCA algorithm did not The critical roles of apoptosis and hepatitis B in the process of AD were confirmed in the literature [31][32].…”
Section: A Biological Significancementioning
confidence: 86%
“…These QTs have been reported in the past. It was confirmed in [22][23][24]. The JSCCA algorithm did not The critical roles of apoptosis and hepatitis B in the process of AD were confirmed in the literature [31][32].…”
Section: A Biological Significancementioning
confidence: 86%
“…Metabolic reduction or hypoperfusion of the PC can be found in the early stages of AD, even before clinical diagnosis of dementia ( Thomas et al, 2019 ). It is possible that hypoperfusion begins largely in PC and spreads to the parietal cortex and cingulate gyrus along with progression of the AD to other cortical areas ( Aghakhanyan et al, 2018 ). The PC is involved in working memory and its deactivation is associated with early MCI assessed by a validated clinical screening instrument for cognitive decline ( Yokosawa et al, 2020 ).…”
Section: Discussionmentioning
confidence: 99%
“…The PC is involved in working memory and its deactivation is associated with early MCI assessed by a validated clinical screening instrument for cognitive decline ( Yokosawa et al, 2020 ). Moreover, the PC seems to be a region with high vulnerability to β-amyloid (Aβ) deposition, showing major Aβ load in Aβ-PET and in association with cognitive decline in MCI and AD patients compared with healthy controls ( Aghakhanyan et al, 2018 ). White matter microstructure alteration occurs in the early stage of amyloid pathology and the strongest association was found in PC and the corpus callosum ( Collij et al, 2021 ).…”
Section: Discussionmentioning
confidence: 99%
“…The precuneus (PreC) corresponds to the mesial portion of Brodmann Area (BA) 7 and is a hub of the default mode network (DMN) that also includes frontal (BA10), inferior temporal (BA20) and posterior cingulate (BA23) cortices, which are compromised during the early stages of AD 1‐4 . PreC imaging studies show marked hypometabolism 5‐10 and extensive amyloid ligand binding in both mild cognitive impairment (MCI), a prodromal AD stage and frank AD 1,11,12 . However, this DMN node displays a resilience to synaptic loss, 13 maintenance of neurotrophic proteins 1,3 and limited numbers of neurofibrillary tangles (NFTs) during the onset of AD 3,14 .…”
Section: Introductionmentioning
confidence: 99%
“…However, this DMN node displays a resilience to synaptic loss, 13 maintenance of neurotrophic proteins 1,3 and limited numbers of neurofibrillary tangles (NFTs) during the onset of AD 3,14 . Despite evidence of early cellular and metabolic dysregulation and resilience to neuropathology, 8,12 very little is known about alterations in cellular chromosomal ribonucleoproteins, telomeres, in prodromal AD. In this regard, mounting evidence suggests that telomeres and telomere maintenance proteins, which modulate neuronal responses to both oxidative stress and DNA damage, 15‐18 are novel therapeutic targets 17,19 and biomarkers for AD 20,21 .…”
Section: Introductionmentioning
confidence: 99%